VALORANT Champions Tour 2024: China Stage 2
                            
                        
                    Lower Bracket R1
                        
                游戏
            
                            
                游戏 1
                Ascent 
            
                    
                游戏 2
                Icebox 
            
                    
                游戏 3
                Lotus 
            
            kda
                        +/-
                        ACS
                        評価 1.1
                        KAST
                        ADR
                        hs%
                        影响
                        fk
                        fd
                        F+/-
                        mk
                        交易
                        离合器
                    
                                    61 / 40 / 22
                                                                    
                                
                                    +21
                                                                    
                                
                                    265.66
                                                                    
                                
                                    1.78
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    35%
                                                                    
                                
                                    148
                                                                    
                                
                                    12
                                                                    
                                
                                    5
                                                                    
                                
                                    +7
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    60 / 48 / 8
                                                                    
                                
                                    +12
                                                                    
                                
                                    250.65
                                                                    
                                
                                    1.39
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    27%
                                                                    
                                
                                    213
                                                                    
                                
                                    18
                                                                    
                                
                                    5
                                                                    
                                
                                    +13
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    43 / 37 / 16
                                                                    
                                
                                    +6
                                                                    
                                
                                    184.26
                                                                    
                                
                                    1.39
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    26%
                                                                    
                                
                                    56
                                                                    
                                
                                    5
                                                                    
                                
                                    6
                                                                    
                                
                                    -1
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    42 / 40 / 21
                                                                    
                                
                                    +2
                                                                    
                                
                                    172.00
                                                                    
                                
                                    1.23
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    41%
                                                                    
                                
                                    32
                                                                    
                                
                                    -
                                                                    
                                
                                    3
                                                                    
                                
                                    -3
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    42 / 42 / 25
                                                                    
                                
                                    0
                                                                    
                                
                                    195.55
                                                                    
                                
                                    1.17
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    29%
                                                                    
                                
                                    59
                                                                    
                                
                                    4
                                                                    
                                
                                    7
                                                                    
                                
                                    -3
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            kda
                        +/-
                        ACS
                        評価 1.1
                        KAST
                        ADR
                        hs%
                        影响
                        fk
                        fd
                        F+/-
                        mk
                        交易
                        离合器
                    
                                    47 / 48 / 24
                                                                    
                                
                                    -1
                                                                    
                                
                                    212.82
                                                                    
                                
                                    1.14
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    25%
                                                                    
                                
                                    64
                                                                    
                                
                                    3
                                                                    
                                
                                    6
                                                                    
                                
                                    -3
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    51 / 51 / 7
                                                                    
                                
                                    0
                                                                    
                                
                                    222.57
                                                                    
                                
                                    1.07
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    23%
                                                                    
                                
                                    98
                                                                    
                                
                                    13
                                                                    
                                
                                    15
                                                                    
                                
                                    -2
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    35 / 46 / 29
                                                                    
                                
                                    -11
                                                                    
                                
                                    155.08
                                                                    
                                
                                    0.93
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    20%
                                                                    
                                
                                    136
                                                                    
                                
                                    2
                                                                    
                                
                                    2
                                                                    
                                
                                    0
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    39 / 51 / 32
                                                                    
                                
                                    -12
                                                                    
                                
                                    170.82
                                                                    
                                
                                    0.92
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    23%
                                                                    
                                
                                    127
                                                                    
                                
                                    5
                                                                    
                                
                                    9
                                                                    
                                
                                    -4
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            
                                    34 / 52 / 13
                                                                    
                                
                                    -18
                                                                    
                                
                                    155.62
                                                                    
                                
                                    0.75
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    30%
                                                                    
                                
                                    68
                                                                    
                                
                                    3
                                                                    
                                
                                    7
                                                                    
                                
                                    -4
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                                
                                    -
                                                                    
                            博彩公司
                    
                        FPX
                        vs
                        Bilibili
                    
                过去的比赛
日期
                比赛
                事件
            过去的比赛
日期
                比赛
                事件
            
                                                                                
                    
                        
                            2024-07-18 10:00:00
                        
                        
                        
                            
                                
                                Bilibili
                            
                            
                                                                    
                                        1
                                    
                                    -
                                    
                                        2
                                    
                                                            
                            
                                FPX
                                
                            
                        
                        
                            VALORANT Champions Tour 2024: China Stage 2
                        
                        
                    
                                                                                
                    
                        
                            2024-07-17 10:20:00
                        
                        
                        
                            
                                
                                Bilibili
                            
                            
                                                                    
                                        1
                                    
                                    -
                                    
                                        2
                                    
                                                            
                            
                                EDward
                                
                            
                        
                        
                            VALORANT Champions Tour 2024: China Stage 2
                        
                        
                    
                                                                                
                    
                        
                            2024-07-16 10:30:00
                        
                        
                        
                            
                                
                                Bilibili
                            
                            
                                                                    
                                        2
                                    
                                    -
                                    
                                        0
                                    
                                                            
                            
                                JDGaming
                                
                            
                        
                        
                            VALORANT Champions Tour 2024: China Stage 2
                        
                        
                    
                                                                                
                    
                        
                            2024-07-06 12:30:00
                        
                        
                        
                            
                                
                                Bilibili
                            
                            
                                                                    
                                        0
                                    
                                    -
                                    
                                        2
                                    
                                                            
                            
                                EDward
                                
                            
                        
                        
                            VALORANT Champions Tour 2024: China Stage 2
                        
                        
                    
                                    
                    
                        
                            2024-06-30 09:00:00
                        
                        
                        
                            
                                
                                Bilibili
                            
                            
                                                                    
                                        2
                                    
                                    -
                                    
                                        0
                                    
                                                            
                            
                                Dragon RG
                                
                            
                        
                        
                            VALORANT Champions Tour 2024: China Stage 2
                        
                        
                    
                                                                                
                    
                        
                            2024-06-23 12:20:00
                        
                        
                        
                            
                                
                                Bilibili
                            
                            
                                                                    
                                        2
                                    
                                    -
                                    
                                        1
                                    
                                                            
                            
                                Nova Esp
                                
                            
                        
                        
                            VALORANT Champions Tour 2024: China Stage 2
                        
                        
                    
                                    
                    
                        
                            2024-06-16 11:10:00
                        
                        
                        
                            
                                
                                Bilibili
                            
                            
                                                                    
                                        2
                                    
                                    -
                                    
                                        0
                                    
                                                            
                            
                                Wolves
                                
                            
                        
                        
                            VALORANT Champions Tour 2024: China Stage 2
                        
                        
                    
                            
        对战记录
Date
                    Match
                    Event
                
                                                                                                                                    
                            
                                
                                    2024-05-04 09:20:00
                                
                                
                                
                                    
                                        
                                        FPX
                                    
                                    
                                                                                    
                                                2
                                            
                                            -
                                            
                                                0
                                            
                                                                            
                                    
                                        Bilibili
                                        
                                    
                                
                                
                                
                                    
                                        VALORANT Champions Tour 2024: China Stage 1
                                    
                                
                            
                                                    
                            
                                
                                    2023-09-26 11:15:00
                                
                                
                                
                                    
                                        
                                        FPX
                                    
                                    
                                                                                    
                                                2
                                            
                                            -
                                            
                                                1
                                            
                                                                            
                                    
                                        Bilibili
                                        
                                    
                                
                                
                                
                                    
                                        VALORANT China Evolution Series Act 1: Variation
                                    
                                
                            
                                                                                                                
                            
                                
                                    2023-06-15 09:00:00
                                
                                
                                
                                    
                                        
                                        FPX
                                    
                                    
                                                                                    
                                                2
                                            
                                            -
                                            
                                                3
                                            
                                                                            
                                    
                                        Bilibili
                                        
                                    
                                
                                
                                
                                    
                                        VALORANT Champions Tour 2023: China Qualifier
                                    
                                
                            
                                                                                                                
                            
                                
                                    2023-05-18 12:25:00
                                
                                
                                
                                    
                                        
                                        FPX
                                    
                                    
                                                                                    
                                                0
                                            
                                            -
                                            
                                                2
                                            
                                                                            
                                    
                                        Bilibili
                                        
                                    
                                
                                
                                
                                    
                                        FGC Valorant Invitational 2023: Act 2
                                    
                                
                            
                                                            
            活动信息
                    VALORANT Champions Tour 2024: China Stage 2
                    
                                                    2024-06-15 00:00:00
                            -
                            2024-07-20 00:00:00
                                            
                
            
                    33
                    比赛
                
                                
                    S-Tier
                    等级
                
            Group Stage
            比赛
            Rounds
            RD
                            积分
                    
                                1
                            
                        Trace
                        
                                                                    4 - 1
                                                            
                        
                                147 - 138
                            
                        
                                +9
                            
                        4
                            
                                2
                            
                        JDGaming
                        
                                                                    4 - 1
                                                            
                        
                                133 - 92
                            
                        
                                +41
                            
                        4
                            
                                3
                            
                        Bilibili
                        
                                                                    3 - 1
                                                            
                        
                                111 - 91
                            
                        
                                +20
                            
                        3
                            
                                4
                            
                        EDward
                        
                                                                    2 - 2
                                                            
                        
                                100 - 94
                            
                        
                                +6
                            
                        2
                            
                                5
                            
                        FPX
                        
                                                                    2 - 3
                                                            
                        
                                137 - 142
                            
                        
                                -5
                            
                        2
                            
                                6
                            
                        AGamers
                        
                                                                    2 - 3
                                                            
                        
                                104 - 116
                            
                        
                                -12
                            
                        2
                            
                                7
                            
                        Nova Esp
                        
                                                                    2 - 2
                                                            
                        
                                109 - 121
                            
                        
                                -12
                            
                        2
                            
                                8
                            
                        TYLOO
                        
                                                                    2 - 3
                                                            
                        
                                119 - 147
                            
                        
                                -28
                            
                        2
                            
                                9
                            
                        Wolves
                        
                                                                    2 - 2
                                                            
                        
                                97 - 100
                            
                        
                                -3
                            
                        2
                            
                                10
                            
                        DRG
                        
                                                                    1 - 3
                                                            
                        
                                91 - 102
                            
                        
                                -11
                            
                        1
                            
                                11
                            
                        Titan EC
                        
                                                                    1 - 4
                                                            
                        
                                132 - 137
                            
                        
                                -5
                            
                        1